The EACPT 2017 Congress was held in Prague from 24th-27th June with 566 participants from all 5 continents – 28% from beyond the European Region, from Australia to China, Japan and South Korea to the USA. The Congress included 22 sessions with Keynote Lectures on current issues for research, education and clinical practice on safe … Read more
Publication: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2). Journal: Lancet 105; 386(10008): 2059–68.
The EACPT is delighted to announce that the 2017 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Professor Pertti Neuvonen from Finland.
Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning. Lancet 2014; 383(9918): 697–704.
The EACPT is delighted to announce that the 2015 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Prof. Michel Eichelbaum from Germany.
Publication: Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation. Journal: Lancet Neurology 2012; 11(7): 589–596
The EACPT is delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Sir Michael Rawlins MD, PhD. from the United Kingdom.
The EACPT is delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Prof. Carlo Patrono from Italy.
Publication: Genetic determinants of response to clopidogrel and cardiovascular events. Journal: New England Journal of Medicine.
The EACPT is delighted to announce that the 2011 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go to Sir Colin Dollery from the United Kingdom.